Form 4 for PGEN PRECIGEN, INC.
Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-29 · accession 0000950103-25-001482 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-03 | 2025-01-29 | PGEN | Thomasian Harry Jr. | Chief Financial Office | A - Grant | $0.00 | +125.0K | 354.4K | +54% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-29 | A | A | 125,000 | $0.00 | 354,376 | D | — | — | (F1) Represent shares of Precigen common stock issued on settlement of the first installment of performance stock units originally granted on August 28, 2024 that vested based on the achievement of the applicable performance condition for such installment. |